UCD spinout Nuritas will mark the commercial release of a sports nutrition product formulated in part by its peptide discovery platform next year.
Nuritas, an Ireland-based peptide discovery platform developer spun out from a University College Dublin (UCD) accelerator program, has closed a €16.8m ($20m) series A round led by VC firm Cultivian Sandbox Ventures, the Irish Times reported today.
Nuritas has developed an automated platform for discovering peptides, molecules found within food that can tackle certain health conditions. The technology uses artificial intelligence (AI) and DNA analysis to match potential peptides with specific health conditions.
The funding will allow Nuritas to target…